Pretzel Therapeutics
Gabriel M. has an extensive work experience in the pharmaceutical industry. Gabriel started their career at Vertex Pharmaceuticals in 2002 as a Sr Scientist and worked there until 2008. Gabriel then joined AstraZeneca as a Principal Scientist and Team Leader from 2008 to 2012. Gabriel then worked at Sage Therapeutics as the Director of Chemistry from 2012 to 2016. Following that, they joined Praxis Precision Medicines, Inc. as the Vice President in 2016 and remained with the company until 2020. Currently, Gabriel is working as the Chief Scientific Officer at Pretzel Therapeutics starting in 2020.
Gabriel M. started their education in 1990 and graduated in 1995 from Universitat de Barcelona. Gabriel then pursued a PhD from Queen Mary University of London, which they completed between 1996 and 1999. No specific field of study is provided for either of their educational experiences.
This person is not in any offices
Pretzel Therapeutics
Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinatingfeatures that make it unlike any other organelle in the body.